Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study

Abstract Background Febrile neutropenia (FN) is a common occurrence during chemotherapy. Granulocyte colony-stimulating factors (G-CSFs) can significantly reduce the risk of FN. International guidelines recommend G-CSF for patients receiving chemotherapy with FN risk of ≥20% or 10% to 20% with defin...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	Bernardo Leon Rapoport, Matti Aapro, Marianne Paesmans, Ronwyn van Eeden, Teresa Smit, Andriy Krendyukov, Jean Klastersky
Format:	Article
Language:	English
Published:	BMC 2018-09-01
Subjects:	Chemotherapy-induced neutropenia Febrile neutropenia Neutropenia Chemotherapy Cytotoxic chemotherapy Myelosuppressive chemotherapy
Online Access:	http://link.springer.com/article/10.1186/s12885-018-4838-z